Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04250766 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR)

Study acronym: BIOPSAR
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 2, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jun 2025 to Jun 2026v4
  2. Enrollment target: estimated 275 to confirmed 19v3 Show 5 more changesShow less
    • Primary completion date: Jan 2022 to Jun 2025
    • Start date changed from estimate of Jun 2020 to Sep 7, 2021
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study completion date: Jan 2025 to Dec 2027
    • Site contact updated
  3. Start date: Jan 2020 to Jun 2020v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Institut Bergonié
40 trials monitored
See 1 trial at risk
Sarcoma
1,026 trials monitored
See 67 trials at risk
This is a prospective multi-center interventional study that will be performed in an effort to assess the diagnostic accuracy performance of preoperative vaginal ultrasound-guided biopsy (VUGB) to detect the exact histology of uterine tumors and thereafter triage cases being eligible for morcellation during laparoscopic resection. Ten tertiary French centers will participate in the present study.
Trial Details
NCT Number NCT04250766
Lead Sponsor Institut Bergonié
Collaborators: GIRCI SOHO
Conditions
(from sponsor)		 Fibroid Uterus, Sarcoma Uterus
Related terms Leiomyoma
Enrollment 19 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov